Get addiction help now: (507) 706-5511

get help now

Get addiction help now: (507) 706-5511

get help now
|

Pharmacological Agents Interacting With Methadone

Time to read: 4 min

Information on NAMA’s website is not
intended as medical advice for individual problems. 

 Appropriate medical professionals
should be consulted regarding addiction and addiction recovery.

 

Pharmacologic
Agents

Clinical
Signs
and Symptoms

Comments

Drugs That Decrease Methadone Levels

Rifampin, phenytoin, carbamazepine, butabarbital
sodium, mephobarbital, phenobarbital, secobarbital, ethanol (chronic),
disulfiram, urinary acidifiers, ascorbic acid

Withdrawal signs

Disulfiram may decrease methadone levels but not
significantly. Not clinically problematic.

Drugs That Increase Methadone Levels

Cimetidine, diazepam, ethanol (acute), fluvoxamine
maleate, ketoconazole, urinary alkalinizers

Increased sedation and other opiate effects

Cimetidine can be used in patients with low trough
methadone levels to prolong action (note: must consider cimetidine
effects on other concurrent medications).

Drugs With Levels Affected by Methadone

Desipramine (DMI), zidovudine (AZT)

Possible increased toxicity of DMI and AZT

Methadone descreases DMI and AZT metabolism; may
increase side effects. Close clinical monitoring needed.

Other Opioid and Analgesic Agents

Naltrexone, malmefene,maloxone, buprenorphine,*
butorphanol,* dezocine,* nalbuphine,* pentazocine,* tramadol

Withdrawal signs

 

 

*

Pain-relievers with opioid-antagonist activity.

Synthetic analgesic (not considered opioid
antagonist, but does decrease levels of opiates).

Data from Stine and Kosten,
Addiction Treatment Forum,
Kalvik et al, and Nillson et al.

This chart
courtesy of MedScape

 
The National Alliance Of Methadone Advocates

 

Similar Posts

  • Annual 2024 NAMA Recovery Conference

    ByAdmin
    Admin 03/07/2024

    Overview Welcome to the official page of the Annual NAMA Recovery Conference! Join us as we explore the latest advancements in medication-assisted treatment (MAT), share success stories, and discuss strategies to overcome challenges in the journey toward recovery. This event brings together patients, healthcare providers, advocates, and policymakers to foster dialogue and drive positive change…

  • The First Patient Advocate’s Illumination Award Sunday, October 7th

    ByAdmin
    Admin 12/19/2021

    The First Patient Advocate’s Illumination Award Sunday, October 7th The Advocate’s Illumination Award is presented to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment. Inscription The Opioid Agonist Treatment Advocacy Community with heartfelt thanks and…

  • |

    Federal Agencies

    ByAdmin
    Admin 10/16/2022

    United States Regulations Code of Federal Regulations 42 Part 8. Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction. Federal Register 17 January 2001. (PDF Format) Publication of Final Rule with comments. 42 Code of Federal Regulations Part 2 . Confidentiality of Alcohol and Drug Abuse Patient Records. New Take Home Regulations. Page 4098…

  • LAAM Warning

    ByAdmin
    Admin 07/05/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • Myths About Methadone by Emmett Velten-3

    ByAdmin
    Admin 08/01/2022

    These facts were important, of course, to Dole and Nyswander, but were completely crucial in their long battle to get government to go along with the idea of methadone maintenance.  Government reflects Americans practical tendency as well as its moralistic, judgmental tendency, and in this case the practical tendency can out on top.  Government allowed…

  • Oral Swabs

    ByAdmin
    Admin 08/23/2022

    Policy Statement Number 13 July 2003 The development of Oral Swabs for toxicology testing shows potential in providing an alternative means to test for drug use and to assess if a patient is taking their medication as prescribed. Such advances in technology should improve the quality of treatment that programs can provide to patients. However…